Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptic remodeling refers to the process by which synapses—the connections between neurons—are physically and functionally altered through the creation, elimination, strengthening, or weakening of synaptic contacts. This phenomenon underlies the brain’s capacity for learning, memory, and adaptation to new experiences. Key actions include synaptogenesis (formation of new synapses), synaptic pruning (elimination of weak or unnecessary synapses), synaptic strengthening (potentiation), and synaptic weakening (depression). Molecular control involves orchestrated activities of neurotransmitter receptors (such as NMDA and AMPA receptors), intracellular signaling cascades (e.g., kinases like CaMKII, PKA), cytoskeletal remodeling, and sometimes, transcriptional and translational regulation. Synaptic remodeling occurs during development, in response to activity and experience, and is implicated in multiple neurological diseases. While not itself a drug target, it is affected indirectly by pharmacological modulators or genetic factors that influence synaptic function and connectivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptic remodeling.